JP2003515623A5 - - Google Patents

Download PDF

Info

Publication number
JP2003515623A5
JP2003515623A5 JP2001541070A JP2001541070A JP2003515623A5 JP 2003515623 A5 JP2003515623 A5 JP 2003515623A5 JP 2001541070 A JP2001541070 A JP 2001541070A JP 2001541070 A JP2001541070 A JP 2001541070A JP 2003515623 A5 JP2003515623 A5 JP 2003515623A5
Authority
JP
Japan
Prior art keywords
per
cyclodextrin
deoxy
thio
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001541070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003515623A (ja
JP3880041B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2000/011789 external-priority patent/WO2001040316A1/en
Publication of JP2003515623A publication Critical patent/JP2003515623A/ja
Publication of JP2003515623A5 publication Critical patent/JP2003515623A5/ja
Application granted granted Critical
Publication of JP3880041B2 publication Critical patent/JP3880041B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001541070A 1999-11-29 2000-11-23 6−メルカプト−シクロデキストリン誘導体:薬物誘導神経筋遮断回復薬 Expired - Lifetime JP3880041B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99309558 1999-11-29
EP99309558.7 1999-11-29
PCT/EP2000/011789 WO2001040316A1 (en) 1999-11-29 2000-11-23 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006195089A Division JP4563972B2 (ja) 1999-11-29 2006-07-18 6−メルカプト−シクロデキストリン誘導体:薬物誘導神経筋遮断回復薬

Publications (3)

Publication Number Publication Date
JP2003515623A JP2003515623A (ja) 2003-05-07
JP2003515623A5 true JP2003515623A5 (enExample) 2006-09-07
JP3880041B2 JP3880041B2 (ja) 2007-02-14

Family

ID=8241767

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001541070A Expired - Lifetime JP3880041B2 (ja) 1999-11-29 2000-11-23 6−メルカプト−シクロデキストリン誘導体:薬物誘導神経筋遮断回復薬
JP2006195089A Expired - Lifetime JP4563972B2 (ja) 1999-11-29 2006-07-18 6−メルカプト−シクロデキストリン誘導体:薬物誘導神経筋遮断回復薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2006195089A Expired - Lifetime JP4563972B2 (ja) 1999-11-29 2006-07-18 6−メルカプト−シクロデキストリン誘導体:薬物誘導神経筋遮断回復薬

Country Status (33)

Country Link
US (3) USRE44733E1 (enExample)
EP (1) EP1259550B1 (enExample)
JP (2) JP3880041B2 (enExample)
KR (1) KR100716524B1 (enExample)
CN (1) CN1188428C (enExample)
AR (1) AR026605A1 (enExample)
AT (1) ATE288450T1 (enExample)
AU (1) AU776536B2 (enExample)
BE (1) BE2008C047I2 (enExample)
BR (1) BRPI0015947B8 (enExample)
CA (1) CA2390463C (enExample)
CO (1) CO5251450A1 (enExample)
CY (1) CY2008018I2 (enExample)
CZ (1) CZ298206B6 (enExample)
DE (2) DE60017947T2 (enExample)
DK (1) DK1259550T3 (enExample)
ES (1) ES2237496T3 (enExample)
FR (1) FR08C0052I2 (enExample)
HU (1) HU227451B1 (enExample)
IL (1) IL149423A0 (enExample)
LU (1) LU91501I2 (enExample)
MX (1) MXPA02004940A (enExample)
NL (1) NL300356I2 (enExample)
NO (2) NO328790B1 (enExample)
NZ (1) NZ518752A (enExample)
PE (1) PE20010902A1 (enExample)
PL (1) PL203012B1 (enExample)
PT (1) PT1259550E (enExample)
RU (1) RU2260013C2 (enExample)
SK (1) SK286282B6 (enExample)
TW (1) TWI242015B (enExample)
WO (1) WO2001040316A1 (enExample)
ZA (1) ZA200203538B (enExample)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6744471B1 (en) * 1997-12-05 2004-06-01 Olympus Optical Co., Ltd Electronic camera that synthesizes two images taken under different exposures
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20040048830A1 (en) * 2000-11-02 2004-03-11 Mingqiang Zhang Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
CN101039682A (zh) 2003-10-31 2007-09-19 堪萨斯大学 磺基烷基醚-烷基醚环糊精衍生物
US7851457B2 (en) 2004-01-29 2010-12-14 Innovative Biologics, Inc. β-Cyclodextrin derivatives
HUE058227T2 (hu) 2004-04-23 2022-07-28 Cydex Pharmaceuticals Inc DPI készítmény, amely szulfoalkil-éter-ciklodextrint tartalmaz
RU2007133709A (ru) 2005-01-28 2009-03-20 Пиннекл Фармасьютиклз, Инк. (Us) Производные в-циклодекстрина в качестве антибактериальных агентов
MX348982B (es) 2005-10-26 2017-07-06 Cydex Pharmaceuticals Inc Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20090069412A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched sugammadex
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US7938283B2 (en) * 2008-06-20 2011-05-10 Grainpro, Inc. System and method for hermetic storage of agricultural commodities during shipping
US10463677B2 (en) 2008-11-07 2019-11-05 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) * 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
ES2551585T3 (es) * 2010-08-25 2015-11-20 Davuluri, Ramamohan Rao Procedimiento mejorado para la preparación de Sugammadex
CN102060941B (zh) 2010-11-26 2012-12-26 漆又毛 6-脱氧α-氨基酸衍生物环糊精及制备和应用
WO2013123254A1 (en) 2012-02-15 2013-08-22 Cydex Pharmaceuticals, Inc. Manufacturing process for cyclodextrin derivatives
US9493582B2 (en) 2012-02-28 2016-11-15 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
JP5892847B2 (ja) * 2012-04-27 2016-03-23 Dowaホールディングス株式会社 シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤
GB201211153D0 (en) * 2012-06-22 2012-08-08 Farmhispania Pharmaceutical compositions
HK1213585A1 (zh) 2012-10-22 2016-07-08 Cydex Pharmaceuticals, Inc. 烷基化环糊精组合物及其制备和使用方法
EP2956486B1 (en) * 2013-02-14 2020-09-30 Neuland Laboratories Ltd An improved process for preparation of sugammadex sodium
JP2017523260A (ja) 2014-05-29 2017-08-17 ユーティーアイ リミテッド パートナーシップ シクロデキストリン系のポリアニオン性デンドリマーおよび非イオン性デンドリマー
JP5684954B1 (ja) 2014-06-26 2015-03-18 丸石製薬株式会社 安定性を改善したロクロニウム製剤
CN105348412B (zh) * 2014-08-22 2018-06-05 江苏恩华药业股份有限公司 一种舒更葡糖钠的纯化方法
EP3183295B1 (en) 2014-08-22 2023-08-02 CyDex Pharmaceuticals, Inc. Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
EP3270941B1 (en) 2015-03-19 2021-05-26 Cydex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104844732B (zh) * 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
JP2018510912A (ja) * 2015-04-08 2018-04-19 リン,チャン−チュン ポリアニオン性および非イオン性のシクロデキストリン系デンドリマーの医薬組成物およびその使用
EP3303413A4 (en) * 2015-05-29 2019-02-06 Alaparthi, Lakshmi Prasad PROCESS FOR THE PREPARATION OF SUGAMMADEX AND INTERMEDIATE PRODUCTS THEREOF
CN104922693A (zh) * 2015-06-19 2015-09-23 南开大学 一种阴离子型环糊精与抗癌药物包合物及制备方法
WO2017059547A1 (en) * 2015-10-07 2017-04-13 Uti Limited Partnership Multifunctional polyanionic cyclodextrin dendrimers
EP3741801A1 (en) 2015-11-25 2020-11-25 Fresenius Kabi iPSUM S.r.l. Crystalline forms of per-chloro-gamma-cyclodextrines
CN108290964B (zh) * 2015-11-25 2021-07-09 费森尤斯卡比依普莎姆有限责任公司 用于制备舒更葡糖及其中间体的改进的方法
CN108779186B (zh) * 2016-03-22 2021-07-13 费森尤斯卡比依普莎姆有限责任公司 一种改进的制备舒更葡萄糖的方法
US10813944B2 (en) 2016-04-29 2020-10-27 Alveron Pharma B.V. Cyclodextrins as procoagulants
EP3474865B1 (en) 2016-06-23 2022-03-02 Synthon BV Process for making sugammadex
WO2017084401A1 (zh) * 2016-06-29 2017-05-26 北京睿创康泰医药研究院有限公司 舒更葡糖钠的制备及纯化方法
US10526422B2 (en) 2016-06-29 2020-01-07 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Process for preparation and purification of Sugammades sodium
CN107778383B (zh) 2016-08-24 2020-03-10 王炳永 一种舒更葡糖钠的精制方法
US10385142B2 (en) 2017-01-23 2019-08-20 Scinopharm Taiwan, Ltd. Method for preparing sugammadex sodium
CN110831588B (zh) 2017-05-03 2023-06-27 锡德克斯药物公司 包含环糊精和白消安的组合物
CN109021148B (zh) * 2017-06-08 2020-11-10 天津科伦药物研究有限公司 一种制备舒更葡糖钠的方法
US10442871B2 (en) 2017-06-22 2019-10-15 Lawrence Livermore National Security, Llc Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof
ES2761899T3 (es) 2017-06-30 2020-05-21 Synthon Bv Proceso para preparar Sugammadex
TWI703163B (zh) * 2017-08-23 2020-09-01 台耀化學股份有限公司 舒更葡糖鈉之製備方法及其晶型
US10233263B1 (en) * 2017-08-23 2019-03-19 Formosa Laboratories, Inc. Method for preparation of sugammadex sodium
EP3717521B1 (en) 2017-11-27 2023-04-05 Medichem, S.A. Process for the synthesis of a cyclodextrin derivative
CN107892727B (zh) * 2017-11-27 2019-12-24 合肥博思科创医药科技有限公司 一种舒更葡糖钠的纯化方法
US11225565B2 (en) 2018-04-06 2022-01-18 Synthon B.V. Purification of sugammadex
KR102054228B1 (ko) * 2018-05-28 2019-12-10 연성정밀화학(주) 슈가마덱스 나트륨염의 제조방법
KR102782805B1 (ko) * 2018-06-07 2025-03-14 머크 샤프 앤드 돔 엘엘씨 슈가마덱스의 제조 방법
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
EP3830184B1 (en) * 2018-08-02 2025-04-30 TAPI Croatia Industries Ltd Solid state forms of sugammadex sodium
US11845811B2 (en) * 2018-09-20 2023-12-19 Natco Pharma Limited Process for the preparation of Sugammadex sodium and its novel polymorphic form
JP2022501489A (ja) * 2018-09-27 2022-01-06 ヴェルテンシュタイン・バイオファーマ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング スガマデクスの新規結晶型
JP6950966B2 (ja) * 2018-11-01 2021-10-13 丸石製薬株式会社 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
CN109438591B (zh) * 2018-12-29 2021-02-09 博瑞生物医药(苏州)股份有限公司 舒更葡糖钠的制备工艺
CN109824800A (zh) * 2018-12-29 2019-05-31 鼎元(天津)生物医药科技有限公司 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法
US20220169753A1 (en) 2019-03-29 2022-06-02 Hospira, Inc. An improved process for preparation of sugammadex acid and sugammadex sodium
CN111978435B (zh) 2019-05-22 2021-05-25 合肥博思科创医药科技有限公司 一种高纯度舒更葡糖钠的制备方法
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
JP7617844B2 (ja) * 2019-08-30 2025-01-20 テルモ株式会社 注射液製剤
RU2724900C1 (ru) * 2019-10-24 2020-06-26 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN111019016B (zh) * 2019-12-27 2022-02-18 武汉嘉诺康医药技术有限公司 一种舒更葡糖钠杂质的合成方法
US20230167203A1 (en) 2020-02-28 2023-06-01 Medichem, S.A. Method for drying sugammadex
CN111714459B (zh) * 2020-06-18 2022-06-14 广州瑞尔医药科技有限公司 一种注射用舒更葡糖钠粉针剂及其制备方法
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
ES2949710T1 (es) 2020-07-03 2023-10-02 Galenicum Health S L U Método para preparar composiciones farmacéuticas
US11446325B2 (en) * 2020-09-30 2022-09-20 Cyclolab Cyclodextrin Research And Development Laboratory Ltd. Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases
US11945788B2 (en) 2021-06-07 2024-04-02 Nuray Chemicals Private Limited Process for preparing pitolisant hydrochloride and solid-state forms thereof
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用
CN115708777A (zh) 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法
CN119679816A (zh) * 2023-09-15 2025-03-25 杭州奥默医药股份有限公司 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物
EP4656660A1 (en) * 2024-05-31 2025-12-03 Universidad de Almeria Alfa-, beta-, and gamma- cyclodextrin derivatives decorated with (2-mercaptoethyl)phosphonic acid branches, synthesis and applications

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
JPS52108027A (en) 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
US4816462A (en) 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
JP2792610B2 (ja) 1989-04-03 1998-09-03 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ シクロデキストリンの区域選択的置換
US5173481A (en) 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
SU1703657A1 (ru) * 1990-01-23 1992-01-07 Пятигорский фармацевтический институт Соединение включени диэтиламида никотиновой кислоты и @ -циклодекстрина, про вл ющее пролонгированное аналептическое действие
DK0447171T3 (da) * 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5180176A (en) * 1991-08-08 1993-01-19 Far Great Plastics Industrial Co., Ltd. Elastic truck for roller skates
JP2556236B2 (ja) 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法
DE69942317D1 (de) 1998-05-29 2010-06-10 Neurosciences Res Found Schmerzlinderung mit anandamide
CN1241576C (zh) 1999-08-13 2006-02-15 阿克佐诺贝尔公司 化学螯合剂用于制备逆转临床使用的神经肌肉传导阻滞剂药物诱发的神经肌肉传导阻滞的药物的用途
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20020111377A1 (en) 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
WO2002064635A1 (en) 2001-02-14 2002-08-22 Akzo Nobel N.V. 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Similar Documents

Publication Publication Date Title
JP2003515623A5 (enExample)
KR100716524B1 (ko) 6-메르캅토시클로덱스트린 유도체: 약물 유도 신경근차단용 반전제
DE69426811T2 (de) Polyaminierte Liganden, Metallkomplexe, Verfahren zur Herstellung und diagnostische und therapeutische Verwendungen
JP4633927B2 (ja) 治療用ジヌクレオチドおよび誘導体
JP7656669B2 (ja) マトリックスメタロプロテイナーゼ(mmp)阻害剤及びその使用方法
HRP20160046T1 (hr) Poboljšana citotoksiäśna sredstva koja sadrže nove majtanzinoide
JPH07107020B2 (ja) カルバサイクリン誘導体のシクロデキストリンクラスレート
ITMI941074A1 (it) Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
NO174048B (no) Makrocykliske forbindelser og diagnostiske midler inneholdende disse
KR930005980A (ko) 1,2-디하이드로-2-옥소피리딘
IE49948B1 (en) Tri-iodised 5-aminoisophthalic acid derivatives
JPS5919959B2 (ja) トリフルオルメチルニルカプトアセトアミドセフアロスポリン類の製法
RU2006124856A (ru) Гидронопольные производные в качестве агонистов по отношению к orl1 рецепторам человека
CS214834B2 (en) Method of making the bis-amids of the 5-amino-2,4,6-triiodizophtale acid
EP0300828A1 (en) Iodinated esters
JPS6123197B2 (enExample)
JP2001504843A (ja) 大環状金属錯体カルボン酸、その使用並びにその製造法
JPS59167551A (ja) 臭素化合物含有x線造影剤
JPH09505813A (ja) ビフェニル沃素化誘導体及びその診断用途
KR830000678B1 (ko) 세팔로스포린 에스테르 및 에테르의 제조방법
CA1104560A (en) Pyrrole cephalosporin derivatives
JPS635038B2 (enExample)
JPS5519268A (en) Pyrimidine derivative and medical composition
JPS5813593A (ja) アミノメチルホスホン酸誘導体
PT93597B (pt) Processo para a preparacao de derivados cefalosporanicos polares e de composicoes farmaceuticas que os contem